Brazil still ranks 67th in the global ranking for the application of vaccine doses against it COVID-19 This Saturday (19) for every 100 people. The country, which started vaccination five months ago, was already 56th in this ranking, and last week it was 68th.
Among the countries that make up the G20, a grouping of the world’s 20 largest economies, the country remains in tenth place. According to the data updated by CNN agencyIn Brazil, there are 40.69 doses applied to every 100 people.
Followed by the United Kingdom at the top of the list, with a rate of 108.06 for every 100 people. The United States comes in second with a score of 94.50. Canada ranked third (83.24), followed by Germany (78.46), Italy (74.46) and France (69.49). China (68.80) came in seventh place, followed by Saudi Arabia (47.27). Turkey appears next, with 44.75 doses applied to every 100 inhabitants.
Given the absolute numbers of vaccination, China continues to lead the ranking, with 990.2 million doses already applied.
The United States is in second place, with 316 million doses applied. Then India comes in with the application of 266.3 million doses. Brazil is still in fourth place, with 86.1 million doses applied – the same situation if we consider the G20 countries.
The United Kingdom ranks fifth, with 73.3 million doses applied in absolute numbers. The data was collected by CNN agency With information from state health departments and from the Our World in Data website, which is linked to the University of Oxford in the UK.
Charlotte Whitmore is a contributor at Mediarunsearch.co.uk, covering a broad range of topics including news, politics, business, technology, sport, entertainment, and lifestyle. She focuses on delivering clear, balanced reporting and practical information that helps readers stay informed about current events and emerging developments. Her work highlights stories that matter to everyday audiences, with an emphasis on accuracy, relevance, and accessible journalism that keeps readers connected to the issues shaping the UK and beyond.